Medicare Enrolled
Dr. Rodney Laningham, MD
Family Medicine · Conroe, TX
Practice pattern: Mixed Practice— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Laningham from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Laningham? Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Laningham
Dr. Rodney Laningham is a family medicine in Conroe, TX, with 19 years in practice. Based on federal Medicare data, Dr. Laningham performed 68,313 Medicare services across 10,503 unique beneficiaries.
Between the years covered by Open Payments, Dr. Laningham received a total of $7,061 from 51 pharmaceutical and/or device companies across 347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in family medicine. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Laningham is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years in practice▲ Top 0% volume in TX$ $7,061 industry payments
Medicare Practice Summary
Medicare Utilization ↗68,313
Medicare services
Top 0% in TX for family medicine
10,503
Unique beneficiaries
$9
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,595 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Testosterone injection | 46,200 | $0 | $0 |
| Dexamethasone injection (steroid) | 3,676 | $0 | $6 |
| Office visit, established patient (30-39 min) | 1,891 | $79 | $254 |
| Blood draw (venipuncture) | 1,177 | $8 | $20 |
| Office visit, established patient, complex (40-54 min) | 1,176 | $119 | $340 |
| Drug injection, under skin or into muscle | 1,083 | $9 | $60 |
| Complete blood count (CBC) with differential | 1,060 | $8 | $27 |
| Comprehensive metabolic blood panel | 1,025 | $10 | $36 |
| Thyroid stimulating hormone (TSH) test | 985 | $16 | $58 |
| Lipid panel (cholesterol and triglycerides) | 973 | $13 | $46 |
| Hemoglobin A1c test (diabetes monitoring) | 950 | $10 | $33 |
| Ceftriaxone antibiotic injection | 832 | $0 | $13 |
| Vitamin D level test | 771 | $29 | $93 |
| Injection, ketorolac tromethamine, per 15 mg | 696 | $0 | $12 |
| Annual alcohol misuse screening, 5 to 15 minutes | 474 | $18 | $43 |
| Annual wellness visit, follow-up | 463 | $123 | $266 |
| Annual depression screening | 453 | $18 | $43 |
| Free thyroxine (T4) test | 410 | $9 | $31 |
| Thyroid hormone, t3 measurement, free | 409 | $17 | $58 |
| Infectious disease DNA/RNA test | 387 | $34 | $88 |
| Testosterone (hormone) level, total | 385 | $25 | $89 |
| Steroid injection (triamcinolone) | 254 | $1 | $4 |
| Face-to-face behavioral counseling for obesity, 15 minutes | 242 | $24 | $61 |
| Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | 238 | $25 | $61 |
| Urinalysis, manual | 225 | $3 | $10 |
| Prostate cancer screening; prostate specific antigen test (psa) | 184 | $19 | $63 |
| Identification of organisms by genetic analysis, amplified probe technique | 168 | $34 | $88 |
| Office visit, established patient (20-29 min) | 135 | $60 | $173 |
| Destruction of precancerous skin growths, 2-14 | 130 | $4 | $37 |
| Detection test by nucleic acid for multiple organisms, amplified probe(s) technique | 129 | $69 | $176 |
| Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | 111 | $1 | $10 |
| PSA test (prostate cancer screening) | 105 | $18 | $63 |
| Administration and interpretation of patient-focused health risk assessment | 105 | $1 | $35 |
| Prothrombin time test (blood clotting) | 104 | $4 | $14 |
| Transitional care management services for problem of high complexity | 89 | $211 | $549 |
| Electrocardiogram (EKG), 12-lead | 82 | $9 | $43 |
| Detection test by nucleic acid for strep (streptococcus, group a), amplified probe technique | 52 | $34 | $88 |
| Office visit, established patient (10-19 min) | 50 | $38 | $103 |
| Detection test by nucleic acid for staphylococcus aureus (bacteria), amplified probe technique | 43 | $34 | $88 |
| Detection test by nucleic acid for strep (streptococcus, group b), amplified probe technique | 43 | $34 | $88 |
| Yeast/candida DNA test | 42 | $34 | $88 |
| Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | 34 | $31 | $98 |
| Destruction of precancerous skin growth, 1 | 33 | $40 | $194 |
| Injection, cefazolin sodium, 500 mg | 30 | $1 | $5 |
| Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | 29 | $151 | $390 |
| New patient office visit (45-59 min) | 28 | $97 | $392 |
| Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | 27 | $40 | $126 |
| Detection test by nucleic acid for staphylococcus aureus, methicillin resistant (mrsa bacteria), amplified probe technique | 24 | $34 | $88 |
| Transitional care management services for problem of at least moderate complexity | 23 | $154 | $388 |
| New patient office visit, complex (60-74 min) | 21 | $125 | $486 |
| Joint injection, major joint | 16 | $41 | $170 |
| Removal of impacted ear wax | 15 | $27 | $125 |
| Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | 15 | $158 | $403 |
| Respiratory infectious agent detection by rna for severe acute respiratory syndrome coronavirus 2 (covid 19), influenza a, influenza b, and respiratory syncytial virus, upper respiratory specimen, each reported as detected or not detected | 11 | $140 | $200 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$7,061
Total received (2018-2024)
Avg $1,009/year across 7 years
Top 8% in TX for family medicine
51
Companies
347
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$5,843 (82.8%)
Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$1,218 (17.2%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024$909
2023$711
2022$848
2021$2,452
2020$750
2019$804
2018$587
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
Biohaven Pharmaceuticals, Inc.
$1,218
Amgen Inc.
$483
AstraZeneca Pharmaceuticals LP
$464
Lilly USA, LLC
$384
Salix Pharmaceuticals, a division of Bausch Health US, LLC
$316
Takeda Pharmaceuticals U.S.A., Inc.
$315
ABBVIE INC.
$294
Abbott Laboratories
$278
GlaxoSmithKline, LLC.
$268
Dexcom, Inc.
$266
Novo Nordisk Inc
$249
SANOFI-AVENTIS U.S. LLC
$214
PFIZER INC.
$175
Boehringer Ingelheim Pharmaceuticals, Inc.
$171
Paratek Pharmaceuticals, Inc.
$155
Novartis Pharmaceuticals Corporation
$150
AbbVie Inc.
$136
DEXCOM, INC.
$128
Allergan, Inc.
$114
Kowa Pharmaceuticals America, Inc.
$91
Eisai Inc.
$77
Antares Pharma, Inc.
$76
Amarin Pharma Inc.
$68
Tolmar, Inc.
$65
Janssen Pharmaceuticals, Inc
$65
JAZZ PHARMACEUTICALS INC.
$63
Esperion Therapeutics, Inc.
$58
Otsuka America Pharmaceutical, Inc.
$55
Allergan Inc.
$54
Exact Sciences Corporation
$52
Biohaven Pharmaceutical Holding Company Ltd.
$42
Supernus Pharmaceuticals, Inc.
$41
Medtronic Vascular, Inc.
$39
Coloplast Corp
$39
Merck Sharp & Dohme Corporation
$38
Teva Pharmaceuticals USA, Inc.
$37
Medtronic, Inc.
$34
Almatica Pharma LLC
$31
Sumitomo Pharma America, Inc.
$29
ARBOR PHARMACEUTICALS, INC.
$28
Inspire Medical Systems, Inc.
$24
Astellas Pharma US Inc
$23
Medtronic MiniMed, Inc.
$22
Axsome Therapeutics, Inc.
$21
IRONWOOD PHARMACEUTICALS, INC
$19
Radius Health, Inc.
$16
Shire North American Group Inc
$16
Tris Pharma Inc
$16
IDORSIA PHARMACEUTICALS US INC
$15
IBSA Pharma Inc.
$12
Ironshore Pharmaceuticals Inc.
$12
Top 3 companies account for 30.7% of total payments
Associated products mentioned in payments ›
AIRSUPRA · AJOVY · ALTIS · ANORO · Aimovig · Amitiza · Axium INS DRG IPG · BASAGLAR · BELSOMRA · BOTOX COSMETIC · BREZTRI · BREZTRI AEROSPHERE · BYSTOLIC · CHANTIX · COMIRNATY · COREVALVE EVOLUT R · ClosureFast · Cologuard Collection Kit · DEXCOM G6 TRANSMITTER · Dayvigo · Dexcom G6 Transmitter · Dyanavel XR · ELIGARD · EMGALITY · ENTRESTO · EVENITY · Edarbi · FARXIGA · FREESTYLE LIBRE 2 · FREESTYLE LIBRE 3 · GEMTESA · Guardian Connect · Horizant · INSPIRE · JANUVIA · JARDIANCE · JATENZO · JORNAY PM · LEQVIO · LINZESS · LOREEV XR · Linzess · Livalo · MOUNJARO · NAPRELAN · NEXLETOL · NEXLIZET · NOCDURNA · NURTEC ODT · NUZYRA · OFEV · Otezla · Ozempic · PREVNAR - 13 · PREVNAR 13 · Proclaim Family of SCS IPGs · QULIPTA · QUVIVIQ · REXULTI · REYVOW · RYBELSUS · Repatha · Rybelsus · SEGLENTIS · SHINGRIX · SOLIQUA 100/33 · SPIRIVA RESPIMAT · STIOLTO RESPIMAT · SUNOSI · SYMBICORT · Sunosi · TOUJEO · TRELEGY ELLIPTA · TRINTELLIX · TROKENDI XR · TRULICITY · Tirosint · Trintellix · Tymlos · UBRELVY · VENASEAL · VRAYLAR · VYVANSE · Vascepa · Veozah · Victoza · Wegovy · XARELTO · XIFAXAN · XYOSTED
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians. Total industry engagement is in the top 8% for family medicine in TX.
Equivalent to $10 per 100 Medicare services performed
Geographic Context
Family Medicines within 10 mi
445
Per 100K population
68.0
County median income
$97,266
Nearest hospital
HCA HOUSTON HEALTHCARE CONROE
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Laningham is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and high industry engagement (low-engagement, top 8%), with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Laningham experienced with testosterone injection?
Based on Medicare claims data, Dr. Laningham performed 46,200 testosterone injection services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Laningham receive payments from pharmaceutical companies?
Yes. Dr. Laningham received a total of $7,061 from 51 companies across 347 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Laningham's costs compare to other family medicines in Conroe?
Dr. Laningham's average Medicare payment per service is $9. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Laningham) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Specialty guide
Understanding Family Medicine
Common procedures, typical costs, and what industry payments mean in family medicine.
Same specialty & city
Family Medicines in Conroe
Browse family medicines in Conroe ranked by procedure volume and transparency data.
Highest volume
Top Family Medicines in TX
Family Medicines ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Family Medicines in TX
Which TX family medicines receive the most from drug and device companies.
By company
Biohaven Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Biohaven Pharmaceuticals, Inc..
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc..
By company
AstraZeneca Pharmaceuticals LP Payments to Doctors
See all physicians who received payments from AstraZeneca Pharmaceuticals LP.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology